Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Voyager Therapeutics Inc..
Voyager Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Voyager Therapeutics Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Voyager Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Voyager Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Voyager Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Voyager Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Voyager Therapeutics Inc.- Key Facts
2.2 Voyager Therapeutics Inc.- Geographic Locations
2.3 Voyager Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Voyager Therapeutics Inc.- Business Divisions
2.5 Voyager Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Voyager Therapeutics Inc. Strategic Analysis Review
3.1 Voyager Therapeutics Inc.- Key Strategies
3.2 Voyager Therapeutics Inc.- Company Outlook Statement
3.3 Voyager Therapeutics Inc.- SWOT Analysis
3.3.1 Voyager Therapeutics Inc.- Key Strengths
3.3.2 Voyager Therapeutics Inc.- Key Weaknesses
3.3.3 Voyager Therapeutics Inc.- Potential Opportunities
3.3.4 Voyager Therapeutics Inc.- Potential Threats
3.4 Voyager Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Voyager Therapeutics Inc.- Business Overview
4.2 Voyager Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Voyager Therapeutics Inc.- Key Products
5.2 Voyager Therapeutics Inc.- Key Service Areas
5.3 Voyager Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Voyager Therapeutics Inc.- Company History
6.2 Voyager Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Voyager Therapeutics Inc.- Income Statements
7.2 Voyager Therapeutics Inc.- Balance Sheet
7.3 Voyager Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Voyager Therapeutics Inc.- Direct Competitors
8.2 Voyager Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Voyager Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Voyager Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!